William John Sibold, President and CEO: Madrigal Pharmaceuticals MDGL Sell · Filed 24/09/11

Trade details

Type: Insider sale
Amount: $1,551,490.29
Shares · price: 6,363 sh · $243.83 a share
Held after: 55,887 sh
Stock: Madrigal Pharmaceuticals MDGL
Person: William John SiboldPresident and CEO
Trade date: 24/09/09
Filed: 24/09/11
Days to filing: 2 days

Sold 10.2% of holdings

Share of holding sold: 10.2%

Madrigal Pharmaceuticals trades, last 26 weeks

What else happened in Madrigal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

William John Sibold's recent trades

William John SiboldPresident and CEO
Planned sale10b5-1 planMadrigal Pharmaceuticals
Planned sale10b5-1 plan
Madrigal Pharmaceuticals
MDGL
$2.8M
5,221 sh
$2.8M
Filed 09/11
Traded 09/11
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$3.4M
6,362 sh
$3.4M
Filed 09/09
Traded 09/09
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$1.4M
2,500 sh
$1.4M
Filed 07/20
Traded 07/20
William John SiboldPresident and CEO
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$718.3K
1,663 sh
$718.3K
Filed 03/06
Traded 03/06
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$730.6K
1,663 sh
$730.6K
Filed 03/06
Traded 03/06